Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van der Ende

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Stroke|June 8, 2022
Determinants of Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: A Retrospective Cohort StudyWouter van der Steen, Nadinda A M van der Ende, Katinka R van Kranendonk, et al.
Journal of Neurointerventional Surgery|October 19, 2022
Type of intracranial hemorrhage after endovascular stroke treatment: association with functional outcomeWouter van der Steen, Nadinda A M van der Ende, Sven P R Luijten, et al.
Trials|August 9, 2022
Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trialNadinda A M van der Ende, Bob Roozenbeek, Lucas E M Smagge, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 3, 2025
Patients' Attitude toward Less Frequent Surveillance of Low-Risk Pancreatic Cysts: A Multicenter European Cohort StudyMarloes L J A Sprij, Inge M C M de Kok, Daan D Nieboer, et al.
Stroke|December 5, 2019
National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic StrokeVicky Chalos, Nadinda A M van der Ende, Hester F Lingsma, et al.
JAMA Neurology|May 22, 2023
Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical TrialNadinda A M van der Ende, Bob Roozenbeek, Lucas E M Smagge, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Stroke|June 8, 2022
Determinants of Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: A Retrospective Cohort StudyWouter van der Steen, Nadinda A M van der Ende, Katinka R van Kranendonk, et al.
Journal of Neurointerventional Surgery|October 19, 2022
Type of intracranial hemorrhage after endovascular stroke treatment: association with functional outcomeWouter van der Steen, Nadinda A M van der Ende, Sven P R Luijten, et al.
Trials|August 9, 2022
Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trialNadinda A M van der Ende, Bob Roozenbeek, Lucas E M Smagge, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 3, 2025
Patients' Attitude toward Less Frequent Surveillance of Low-Risk Pancreatic Cysts: A Multicenter European Cohort StudyMarloes L J A Sprij, Inge M C M de Kok, Daan D Nieboer, et al.
Stroke|December 5, 2019
National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic StrokeVicky Chalos, Nadinda A M van der Ende, Hester F Lingsma, et al.
JAMA Neurology|May 22, 2023
Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical TrialNadinda A M van der Ende, Bob Roozenbeek, Lucas E M Smagge, et al.
Pageof 4